Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1989 Dec;86(23):9499–9503. doi: 10.1073/pnas.86.23.9499

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

B I Lord 1, M H Bronchud 1, S Owens 1, J Chang 1, A Howell 1, L Souza 1, T M Dexter 1
PMCID: PMC298524  PMID: 2480603

Abstract

Cell proliferation in the bone marrow and blood of two patients with metastatic breast cancer who were treated with granulocyte colony-stimulating factor was studied by using [3H]thymidine labeling and autoradiography. Additionally, the fate of neutrophils labeled with 99mTc-hexamethylpropyleneamineoxime was observed following granulocyte colony-stimulating factor infusion. Proliferation increased in all stages of granulopoiesis, but a significant amount of the increased production stemmed from a greater input to the myeloblast compartment. Changes in the myelogram combined with the increased labeling indicated a faster throughput of cells, which resulted in labeled cells appearing in the circulation within 1 day compared to the normal 4 or 5 days. The 99mTc studies demonstrated no sequestration of circulating neutrophils by spleen, lungs, or liver. The half-life of the circulating neutrophils was not significantly changed, and calculations from the flow of labeled cells to the peripheral blood indicated an increase of 3.2 extra amplification divisions during neutrophil development. The dramatic neutrophil response to granulocyte colony-stimulating factor can therefore be accommodated by a relatively modest increase in granulopoietic activity.

Full text

PDF
9499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATHENS J. W., HAAB O. P., RAAB S. O., MAUER A. M., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest. 1961 Jun;40:989–995. doi: 10.1172/JCI104338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boggs D. R., Marsh J. C., Chervenick P. A., Cartwright G. E., Wintrobe M. M. Neutrophil releasing activity in plasma of normal human subjects injected with endotoxin. Proc Soc Exp Biol Med. 1968 Mar;127(3):689–693. doi: 10.3181/00379727-127-32774. [DOI] [PubMed] [Google Scholar]
  3. Bronchud M. H., Howell A., Crowther D., Hopwood P., Souza L., Dexter T. M. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer. 1989 Jul;60(1):121–125. doi: 10.1038/bjc.1989.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bronchud M. H., Potter M. R., Morgenstern G., Blasco M. J., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer. 1988 Jul;58(1):64–69. doi: 10.1038/bjc.1988.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bronchud M. H., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer. 1987 Dec;56(6):809–813. doi: 10.1038/bjc.1987.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CRADDOCK C. G., Jr, PERRY S., VENTZKE L. E., LAWRENCE J. S. Evaluation of marrow granulocytic reserves in normal and disease states. Blood. 1960 Jun;15:840–855. [PubMed] [Google Scholar]
  7. CRONKITE E. P., FLIEDNER T. M., BOND V. P., RUBINI J. R. Dynamics of hemopoietic proliferation in man and mice studied by H3-thymidine incorporation into DNA. Ann N Y Acad Sci. 1959 Jun 25;77:803–820. doi: 10.1111/j.1749-6632.1959.tb36943.x. [DOI] [PubMed] [Google Scholar]
  8. Cohen A. M., Zsebo K. M., Inoue H., Hines D., Boone T. C., Chazin V. R., Tsai L., Ritch T., Souza L. M. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2484–2488. doi: 10.1073/pnas.84.8.2484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Devereux S., Linch D. C., Campos Costa D., Spittle M. F., Jelliffe A. M. Transient leucopenia induced by granulocyte-macrophage colony-stimulating factor. Lancet. 1987 Dec 26;2(8574):1523–1524. doi: 10.1016/s0140-6736(87)92654-7. [DOI] [PubMed] [Google Scholar]
  10. FLIEDNER T. M., CRONKITE E. P., KILLMANN S. A., BOND V. P. GRANULOCYTOPOIESIS. II. EMERGENCE AND PATTERN OF LABELING OF NEUTROPHILIC GRANULOCYTES IN HUMANS. Blood. 1964 Dec;24:683–700. [PubMed] [Google Scholar]
  11. FLIEDNER T. M., CRONKITE E. P., ROBERTSON J. S. GRANULOCYTOPOIESIS. I. SENESCENCE AND RANDOM LOSS OF NEUTROPHILIC GRANULOCYTES IN HUMAN BEINGS. Blood. 1964 Oct;24:402–414. [PubMed] [Google Scholar]
  12. Gabrilove J. L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M. A., Clarkson B. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med. 1988 Jun 2;318(22):1414–1422. doi: 10.1056/NEJM198806023182202. [DOI] [PubMed] [Google Scholar]
  13. KILLMANN S. A., CRONKITE E. P., FLIEDNER T. M., BOND V. P. MITOTIC INDICES OF HUMAN BONE MARROW CELLS. 3. DURATION OF SOME PHASES OF ERYTHROCYTIC AND GRANULOCYTIC PROLIFERATION COMPUTED FROM MITOTIC INDICES. Blood. 1964 Sep;24:267–280. [PubMed] [Google Scholar]
  14. KILLMANN S. A., CRONKITE E. P., ROBERTSON J. S., FLIEDNER T. M., BOND V. P. Estimation of phases of the life cycle of leukemic cells from labeling in human beings in vivo with tritiated thymidine. Lab Invest. 1963 Jul;12:671–684. [PubMed] [Google Scholar]
  15. Moore M. A., Warren D. J. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7134–7138. doi: 10.1073/pnas.84.20.7134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988 Mar 26;1(8587):667–672. doi: 10.1016/s0140-6736(88)91475-4. [DOI] [PubMed] [Google Scholar]
  17. Niskanen E., Tyler W. S., Symann M., Stohlman F., Jr, Howard D. The effect of neutropenia on the cell cycle of granulocyte precursors in an in vivo culture system. Blood. 1974 Jan;43(1):23–31. [PubMed] [Google Scholar]
  18. Peters A. M., Danpure H. J., Osman S., Hawker R. J., Henderson B. L., Hodgson H. J., Kelly J. D., Neirinckx R. D., Lavender J. P. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet. 1986 Oct 25;2(8513):946–949. doi: 10.1016/s0140-6736(86)90601-x. [DOI] [PubMed] [Google Scholar]
  19. Souza L. M., Boone T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewski J., Lu H., Chen K. K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986 Apr 4;232(4746):61–65. doi: 10.1126/science.2420009. [DOI] [PubMed] [Google Scholar]
  20. Stryckmans P., Cronkite E. P., Fache J., Fliedner T. M., Ramos J. Deoxyribonucleic acid synthesis time of erythropoietic and granulopoietic cells in human beings. Nature. 1966 Aug 13;211(5050):717–720. doi: 10.1038/211717a0. [DOI] [PubMed] [Google Scholar]
  21. Vincent P. C., Cronkite E. P., Greenberg M. L., Kirsten C., Schiffer L. M., Stryckmans P. A. Leukocyte kinetics in chronic myeloid leukemia. I. DNA synthesis time in blood and marrow myelocytes. Blood. 1969 Jun;33(6):843–850. [PubMed] [Google Scholar]
  22. Vincent P. C. Granulocyte kinetics in health and disease. Clin Haematol. 1977 Oct;6(3):695–717. [PubMed] [Google Scholar]
  23. Watari K., Asano S., Shirafuji N., Kodo H., Ozawa K., Takaku F., Kamachi S. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989 Jan;73(1):117–122. [PubMed] [Google Scholar]
  24. Weiss L. Transmural cellular passage in vascular sinuses of rat bone marrow. Blood. 1970 Aug;36(2):189–208. [PubMed] [Google Scholar]
  25. Welte K., Bonilla M. A., Gillio A. P., Boone T. C., Potter G. K., Gabrilove J. L., Moore M. A., O'Reilly R. J., Souza L. M. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med. 1987 Apr 1;165(4):941–948. doi: 10.1084/jem.165.4.941. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES